- Telehealth Visits
- Insurance plan information
Sawona Biswas, MS
Neurogenetics • Genetic Counselor- Telehealth Visits
- Insurance plan information
Sawona Biswas, MS
Neurogenetics • Genetic Counselor- Telehealth Visits
- Insurance plan information
On this page
About me
Sawona Biswas is a genetic counselor and researcher who cares for adults with concerns about genetic disorders. She evaluates patients for genetic conditions and provides counseling, including genetic testing guidance.
Biswas is interested in developing genetic sequencing tests, such as exome and genome sequencing, and conducting population-based genomic studies focused on best ways to interpret and deliver complex genetic information. She is also interested in finding ways to better integrate data from genetic tests into patient care in the clinic and how to personalize this care for better outcomes.
Biswas earned her master's degree in genetic counseling at California State University, Northridge.
Education & training
Board certification
- Certified Genetic Counselor, American Board of Genetic Counseling
Degree
- MS, California State University at Northridge
My expertise
Specialties
- Neurogenetics
- Genetic Counselor
Locations
My focus is on making genetic services more accessible, building bridges to fill knowledge gaps and using the power of genetics to inform care.
My work
Helping patients with puzzling neurological symptoms
Clinical Trials query: q=health_gateway_id_ss%3A%28%223321%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%223321%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Publication%22
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.